Gerofit and Cognition
Relationship of Exercise Frequency, Intensity, and Fitness to Improved Cognition and Biomarkers in Gerofit Participants
1 other identifier
interventional
150
1 country
2
Brief Summary
Over 50% of the Veterans enrolled for VA health care are over the age of 65. Dementia prevalence increases with age, and with the increase in the population of people ages 65 and older, the total number of people with dementia is also increasing. Older Veterans often have comorbid PTSD, major depression and traumatic brain injury so that they are at 2 to 5 times the risk for cognitive impairment and dementia compared to the general population. There is evidence that exercise interventions in sedentary older adults could improve both physical and cognitive function. However, there have been very few studies on the effects of exercise on cognition in older Veterans and do not reflect the broader ethnic and health-status diversity of Veterans. Thus, improved knowledge of the role of exercise on cognition as well as the predictive power of biomarkers could have a major beneficial impact on Veterans' functional independence and quality of life. The investigators hypothesize that participation in the VA Gerofit exercise program will improve cognitive function in older Veterans and that blood and muscle biomarkers will predict these improvements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2023
CompletedFirst Posted
Study publicly available on registry
October 30, 2023
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2029
June 29, 2025
June 1, 2025
4.5 years
October 25, 2023
June 26, 2025
Conditions
Outcome Measures
Primary Outcomes (8)
Memory composite score
HVLT-R, verbal memory and BVMT-R, visual memory
Change from baseline at 3 months
Executive Function composite score
Stroop C, Trails B, Digit span backwards and sequencing from WAIS-IV, verbal fluency, FAS and animals
Change from baseline at 3 months
Total BDNF
Total brain derived neurotrophic factor (BDNF) concentrations in serum
Change from baseline at 3 months
Mature BDNF
Mature brain derived neurotrophic factor (BDNF) concentrations in serum
Change from baseline at 3 months
Memory composite score
HVLT-R, verbal memory and BVMT-R, visual memory
Change from baseline at 12 months
Executive Function composite score
Stroop C, Trails B, Digit span backwards and sequencing from WAIS-IV, verbal fluency, FAS and animals
Change from baseline at 12 months
Total BDNF
Total brain derived neurotrophic factor (BDNF) concentrations in serum
Change from baseline at 12 months
Mature BDNF
Mature brain derived neurotrophic factor (BDNF) concentrations in serum
Change from baseline at 12 months
Study Arms (2)
Gerofit exercise
ACTIVE COMPARATORParticipants enrolled in the Gerofit program
Health education
PLACEBO COMPARATORParticipants enrolled in monthly in-person health education sessions which do not include a physical activity/exercise promotion session
Interventions
Individualized exercise prescription as well as a group exercise class based on physical function assessments offered 3x/week
Scheduled monthly in-person health education discussion sessions covering 12 different health topics not including a physical activity/exercise promotion session
Eligibility Criteria
You may qualify if:
- All Veterans eligible for VA Gerofit program 65 years and older
- Clearance by PCP to participate in Gerofit exercise program
You may not qualify if:
- Inability to perform ADLs
- Significant cognitive impairment
- Inability to function independently without assistance
- Unstable angina; proliferative diabetic retinopathy
- Oxygen dependent
- Unwillingly to commute and/or not able to provide own transportation to Gerofit
- Incontinence
- Open wounds
- Volatile behavioral issue or unable to work successfully in a group environment/setting
- Active substance abuse
- Homelessness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California, 90073-1003, United States
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cathy C Lee, MD
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
- PRINCIPAL INVESTIGATOR
Jonathan M Wanagat, MD PhD
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
- PRINCIPAL INVESTIGATOR
Stacy Wilkins, PhD
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Gerofit intervention vs Health Education Control
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2023
First Posted
October 30, 2023
Study Start
April 1, 2024
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
March 31, 2029
Last Updated
June 29, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share